Search By Initial

Name Index E

• Enarodustat ( JTZ-951 ) (Catalog# : 2073104, Cas# : 1262132-81-9)Enarodustat ( JTZ-951 ) is an orally-active HIF-PH inhibitor with an EC50 of 0.22 Μm
• Empesertib (Catalog# : 2071554, Cas# : 1443763-60-7)Empesertib, also known as BAY1161909, is an orally bioavailable, selective inhibitor
• EIDD-1931 (Catalog# : 2071537, Cas# : 3258-02-4)EIDD-1931 is a promising COVID-19 inhibitor. EIDD-1931 has broad spectrum antiviral a
• ethyl 2-(2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)acetate (Catalog# : 2062030, Cas# : 2107880-93-1)
• Ethacrynic acid (Catalog# : 2061703, Cas# : 58-54-8)Etharcrynic Acid is a compound that inhibits symport of sodium, potassium, and chlori
• EB-3D (Catalog# : 2061302, Cas# : 1839150-63-8（溴化物)EB-3D is a novel potent and selective choline kinase ChoKα inhibitor. EB-3D Induces
• Elexacaftor (Catalog# : 2052801, Cas# : 2216712-66-0)Elexacaftor, also known as VX-445 and WHO 11180, is a next-generation cystic fibrosis
• EC-5026 (Catalog# : 2051508, Cas# : 1809885-32-2)EC5026, also known as BPN-19186, is a first-in-class, potent and orally active solubl
• Ensartinib hydrochloride (Catalog# : 1843212, Cas# : 2137030-98-7)Ensartinib is an orally available small molecule inhibitor of the receptor tyrosine k
• Evenamide HCl (Catalog# : 112594, Cas# : 1092977-06-4)Evenamide HCl ( CAS 1092977-06-4) ,a sodium channel blocker, shows efficacy in a broa
• Evenamide (Catalog# : 112593, Cas# : 1092977-61-1)venamide is a sodium and/or calcium channel modulator. Evenamide may be potentia usef
• ethyl 2-acetyl-4-bromobenzoate (Catalog# : 95071, Cas# : 182567-89-1)ethyl 2-acetyl-4-bromobenzoate；2-ACETYL-4-BROMOBENZOIC ACID ETHYL ESTER
• Ertapenem (Catalog# : 19318, Cas# : 153832-46-3)Ertapenem is a parenteral carbapenem that is highly resistant to inactivation by a wi
• Eprosartan (Catalog# : 192182, Cas# : 133040-01-4)Eprosartan is a competitive and reversible angiotensin II receptor antagonist used fo
• EX-229 free acid (Catalog# : 192153, Cas# : 1219739-36-2)EX-229, also known as AMPK Activator 991, is a novel AMPK activator, increasing AMPK
• Elacridar HCl (Catalog# : 19121, Cas# : 143851-98-3)Elacridar, also known as GF120918A, is a P-glycoprotein (P-gp) inhibitor, and has bee
• E7820 (Catalog# : 1812293, Cas# : 289483-69-8)E7820 is a small molecule and aromatic sulfonamide derivative with potential antiangi
• EMD638683 (Catalog# : 1810253, Cas# : 1181770-72-8)EMD638683 is a potent inhibitor of SGK1 with an IC50 value of 3 μM.
• E2012 (Catalog# : 1810231, Cas# : 870843-42-8)E2012 is a γ-secretase modulator (GSM).
• EBI-2511 (Catalog# : 1810165, Cas# : 2098546-05-3)EBI-2511 is a Highly Potent and Orally Active EZH2 Inhibitor for the Treatment of Non
• Entasobulin (Catalog# : 186293, Cas# : 501921-61-5)Entasobulin is a β-tubulin polymerization inhibitor with potential anticancer activi
• Epothilone D (Catalog# : 186292, Cas# : 189453-10-9)Epothilone D is a natural polyketide compound isolated from the myxobacterium Sorangi
• EZM2302 (Catalog# : 186272, Cas# : 1628830-21-6)EZM2302 is a potent, selective, and orally available arginine methyltransferase CARM1
• Exatecan mesylate (Catalog# : 186271, Cas# : 169869-90-3)Exatecan, also known as DX 8951, is semisynthetic, water-soluble camptothecin derivat
• Efinaconazole (Catalog# : 186213, Cas# : 164650-44-6)Efinaconazole is a triazole antifungal. It is approved for use in Canada and the USA
• Erteberel (Catalog# : 186157, Cas# : 533884-09-2)Erteberel, also known as LY500307, is a selective estrogen receptor beta (ERβ) agoni
• Edonerpic maleate (Catalog# : 18671, Cas# : 519187-97-4)Edonerpic, also known as T-817, is a neuroprotectant.
• Endoxifen E-isomer HCl (Catalog# : 184124, Cas# : 1197194-61-8)Endoxifen E-isomer is a tamoxifen metabolite and potent Selective Estrogen Response M
• Ensartinib ( X396 ) (Catalog# : 184321, Cas# : 1370651-20-9)Ensartinib is an orally available small molecule inhibitor of the receptor tyrosine k
• eCF506 ( NXP 900 ) (Catalog# : 18382, Cas# : 1914078-41-3)eCF506 targets a molecule called Src tyrosine kinase that is required for breast canc